These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10201366)

  • 1. Sugars slide into heparin activity.
    Sinaÿ P
    Nature; 1999 Apr; 398(6726):377-8. PubMed ID: 10201366
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of thrombin-inhibiting heparin mimetics without side effects.
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Nature; 1999 Apr; 398(6726):417-22. PubMed ID: 10201371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From heparin to synthetic antithrombotic oligosaccharides].
    Petitou M
    Bull Acad Natl Med; 2003; 187(1):47-56; discussion 56-7. PubMed ID: 14556453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis of 1,2-cis-amino containing oligosaccharides toward biological investigation.
    Manabe S
    Methods Enzymol; 2010; 478():413-35. PubMed ID: 20816492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide.
    Walenga JM; Jeske WP; Bara L; Samama MM; Fareed J
    Thromb Res; 1997 Apr; 86(1):1-36. PubMed ID: 9172284
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological properties of synthetic glycoconjugate mimics of heparin comprising different molecular spacers.
    Dreef-Tromp CM; Basten JE; Broekhoven MA; van Dinther TG; Petitou M; van Boeckel CA
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2081-6. PubMed ID: 9873490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
    Petitou M; van Boeckel CA
    Angew Chem Int Ed Engl; 2004 Jun; 43(24):3118-33. PubMed ID: 15199558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New antithrombotic oligosaccharides].
    Petitou M; Hérault JP; Bernat A; Driguez PA; Duchaussoy P; Lormeau JC; Herbert JM
    Ann Pharm Fr; 1999 May; 57(3):232-9. PubMed ID: 10427858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of anticoagulant drugs using oligosaccharide chemistry.
    El Hadri A; Petitou M
    Chimia (Aarau); 2011; 65(1-2):14-7. PubMed ID: 21469438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient synthesis of Idraparinux, the anticoagulant pentasaccharide.
    Chen C; Yu B
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3875-9. PubMed ID: 19386495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SR123781A, a synthetic heparin mimetic.
    Herbert JM; Hérault JP; Bernat A; Savi P; Schaeffer P; Driguez PA; Duchaussoy P; Petitou M
    Thromb Haemost; 2001 May; 85(5):852-60. PubMed ID: 11372679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of new synthetic heparin mimetics.
    Hérault JP; Bernat A; Roye F; Michaux C; Schaeffer P; Bono F; Petitou M; Herbert JM
    Thromb Haemost; 2002 Jun; 87(6):985-9. PubMed ID: 12083506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid two-step synthesis of mitrin from heparosan: a replacement for heparin.
    Kuberan B; Beeler DL; Lawrence R; Lech M; Rosenberg RD
    J Am Chem Soc; 2003 Oct; 125(41):12424-5. PubMed ID: 14531682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design and evaluation of heparin-binding foldamers.
    Choi S; Clements DJ; Pophristic V; Ivanov I; Vemparala S; Bennett JS; Klein ML; Winkler JD; DeGrado WF
    Angew Chem Int Ed Engl; 2005 Oct; 44(41):6685-9. PubMed ID: 16094685
    [No Abstract]   [Full Text] [Related]  

  • 16. Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity.
    Grootenhuis PD; Westerduin P; Meuleman D; Petitou M; van Boeckel CA
    Nat Struct Biol; 1995 Sep; 2(9):736-9. PubMed ID: 7552742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarrays of synthetic heparin oligosaccharides.
    de Paz JL; Noti C; Seeberger PH
    J Am Chem Soc; 2006 Mar; 128(9):2766-7. PubMed ID: 16506732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation of fibroblast growth factors by heparin: synthesis, structure, and biological activity of heparin-like oligosaccharides.
    de Paz JL; Angulo J; Lassaletta JM; Nieto PM; Redondo-Horcajo M; Lozano RM; Giménez-Gallego G; Martín-Lomas M
    Chembiochem; 2001 Sep; 2(9):673-85. PubMed ID: 11828504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structure of synthetic oligosaccharides in relation to factor IXa inhibition.
    Hérault JP; Gaich C; Bono F; Driguez PA; Duchaussoy P; Petitou M; Herbert JM
    Thromb Haemost; 2002 Sep; 88(3):432-5. PubMed ID: 12353072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibition.
    Duchaussoy P; Jaurand G; Driguez PA; Lederman I; Ceccato ML; Gourvenec F; Strassel JM; Sizun P; Petitou M; Herbert JM
    Carbohydr Res; 1999 Apr; 317(1-4):85-99. PubMed ID: 10466208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.